Volume 5, Issue 6

Increasing PrEP Uptake in Women

In this issue:

In the US, among women at high risk for acquiring HIV infection, only around 2% have initiated PrEP.  What are the patient, provider, and system barriers to increased PrEP uptake in this vulnerable population?  What can clinicians do to overcome these barriers? 

In this issue, Dr. Rachel Scott, Scientific Director of Women's Health Research at the MedStar Health Research Institute and Assistant Professor of Obstetrics and Gynecology at the Georgetown University School of Medicine, provides some answers. 

Learning objectives:

  • Discuss the importance of HIV prevention and pre-exposure prophylaxis in women.  
  • Describe the barriers — patient-,systemic-, and provider-level — to increasing PrEP utilization in women.

Author:

Rachel Scott, MD, MPH
Rachel Scott, MD, MPH

Scientific Director of Women's Health Research, MedStar Health Research Institute
Associate Chair for Research in the Department of Women’s and Infants’ Services at MedStar Washington Hospital Center
Assistant Professor of Obstetrics and Gynecology, Georgetown University School of Medicine
MedStar Health Research Institute/Washington Hospital Center and Georgetown University School of Medicine

Program Directors:

Ethel D. Weld, MD, PhD

Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
Baltimore, Maryland
(she/her/hers)

Matthew Spinelli, MD, MAS

Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California
(he/him/his)

Justin Alves, RN, FNP-BC, ACRN, CARN, CNE

Nurse Educator
Boston Medical Center
Boston, MA
(he/him/his)

Length of activity:

0.5 hour Physicians
0.5 contact hour Nurses

Launch date: April 3, 2020
Expiration date: April 2, 2022